Glycosylation of the Sodium Channel β4 Subunit is Developmentally Regulated and Involves in Neuritic Degeneration by Zhou, Ting-ting et al.
Int. J. Biol. Sci. 2012, 8 
 
 
http://www.biolsci.org 
630 
I In nt te er rn na at ti io on na al l   J Jo ou ur rn na al l   o of f   B Bi io ol lo og gi ic ca al l   S Sc ci ie en nc ce es s   
2012; 8(5):630-639. doi: 10.7150/ijbs.3684 
Research Paper 
Glycosylation of the Sodium Channel β4 Subunit is Developmentally    
Regulated and Involves in Neuritic Degeneration   
Ting-ting Zhou1, Zhen-wei Zhang1, Jun Liu2, Jian-peng Zhang1, Bing-hua Jiao1  
1.  Department of Biochemistry and Molecular Biology, Second Military Medical University, Shanghai, 200433, China; 
2.  Department of Neurology and Institute of Neurology, Ruijin Hospital affiliated to Shanghai Jiaotong University School of 
Medicine, Shanghai, 200032, China.  
  Corresponding  author:  Department  of  Biochemistry  and  Molecular  Biology,  Second  Military  Medical  University, 
Shanghai  200433,  China.  Tel:  +86-21-81870970-8017;  Fax:  +86-21-65334344,  E-mail  address:  zjp8007202@hotmail.com 
(Jian-peng Zhang), jiaobhua@live.cn (Bing-hua Jiao). 
© Ivyspring International Publisher. This is an open-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/ 
licenses/by-nc-nd/3.0/). Reproduction is permitted for personal, noncommercial use, provided that the article is in whole, unmodified, and properly cited. 
Received: 2011.10.21; Accepted: 2012.04.20; Published: 2012.04.27 
Abstract 
Aberrant protein glycosylation plays major roles in neurodegenerative diseases, including 
Parkinson’s disease (PD). Glycoproteomics showed that the glycosylation of sodium channel 
β4 was significantly increased in human brain tissue. β4-specific antibodies reacted in im-
munoblot assays with the 35- and 38-kDa bands from the membrane fractions isolated from 
neonatal PD transgenic mice but only with the 35-kDa band of the neonatal wild-type mice. 
The size of the 38-kDa immunoreactive protein is in close agreement with previously re-
ported, suggesting heavy glycosylation of this protein in adult wild-type and neonatal PD 
transgenic brain tissues. However, the neonatal wild-type mice membrane fractions only 
contained the 35-kDa immunoreactive protein, and the additional 38-kDa band was not 
shown until postnatal day 7. Enzymatic deglycosylation of the membrane preparations only 
converted the 38-kDa band into a faster migrating protein, which was consistent with heavy 
glycosylation of this protein. The glycosylated state of β4 was developmentally regulated and 
was altered in disease state. Neurite outgrowth assay demonstrated that overexpression of 
deglycosylated mutant β4-MUT accelerated neurite extension and increased the number of 
filopodia-like protrusions, when compared with β4-WT and the vector. These results suggest 
that extensive glycosylation of β4 subunit play roles in morphological changes, and the altered 
glycosylation may be involved in the pathogenesis of PD. 
Key words: Voltage-gated sodium channel β4 subunit; Glycosylation; Filopodia-like protrusion; 
Neurite outgrowth; Parkinson’s disease. 
Introduction 
Voltage-gated sodium channel (VGSC) β subu-
nits are required for normal kinetics and also partici-
pate in invasion, aggregation, migration, axonal fas-
ciculation, and neurite outgrowth [1-6]. β4 is an aux-
iliary subunit similar to β2 subunit and is associated 
with α subunits by covalent linkages [7]. Structurally, 
β4 consists of an N-terminal cleaved signal sequence, 
an extracellular V-type Ig-like fold, a transmembrane 
domain, and an intracellular region. Co-expression of 
β4 with Nav1.2 or Nav1.4 in the human embryonic cell 
line tsA-201 resulted in a negative shift and increased 
membrane excitability [7]. It has been shown that β4 
subunit  was  the  first  endogenous  blocking  protein 
responsible for resurgent kinetics. The peptide of β4 
was necessary for generating a resurgent current and 
influenced the Na+ channel gating and action potential 
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firing  when  β4  subunit  was  knocked  down  in  cul-
tured  cerebellar  granule  neurons  [8,  9].  β4  subunit 
was  down-regulated  in  Huntington’s  disease  trans-
genic mice, overexpression of β4 induced neurite ex-
tension  and  increased  the  spine  density  [10].  Fur-
thermore,  β4  subunit  regulated  neurite  length  and 
filopodia-like protrusion density in cultured cells [6].  
All subunits of the VGSCs are extensively gly-
cosylated, with 15–40% of their total mass estimated 
to consist of the carbohydrates [11, 12]. The β4 is pre-
dicted to have four potential N-linked glycosylation 
sites in the extracellular region. The molecular mass of 
β4 subunit is greater than the predicted 22 kDa by its 
amino acid sequence; thus, β4 is thought to be glyco-
sylated  in  the  mature  protein  [7].  Aberrant  protein 
glycosylation has been shown to play major roles in 
human  disorders,  including  neurodegenerative  dis-
eases [13-15]. Parkinson’s  disease (PD) is associated 
with α–synuclein pathology and is accompanied by 
the formation of intraneuronal inclusions called Lewy 
bodies [16, 17]. A connection has been demonstrated 
between dysfunction of the parkin and the formation 
of  α–synuclein  inclusions;  the  mechanism  of  this 
process may be due to parkin’s function as an E3 lig-
ase,  which  is  to  mediate  the  ubiquitination  of  an 
O-linked  glycosylated  form  of  α–synuclein  [18,  19]. 
However,  very  little  has  been  elucidated  about  the 
role of glycoproteins in PD progression until now.  
Our  previous  research  was  an  ongoing  study 
where  the  glycoproteins  were  isolated  from  human 
cerebrospinal fluid (CSF) [20]. The brain tissues were 
also  characterized  in  different  stages  of  PD  and  in 
controls.  Herein,  we  quantitatively  compared  the 
protein profiles of brain tissues with PD at different 
pathological stages of disease with age-matched con-
trols. The study revealed many novel proteins with 
quantitative  expression  differences  as  the  disease 
progressed and provided additional insight into the 
molecular  mechanism  of  one  of  these  proteins.  The 
glycosylation of β4 may be involved in PD progres-
sion. 
Materials and methods 
Animals  
Brain  tissues  were  collected  from  adult  and 
postnatal  [postnatal  day  0  (P0),  P2,  P4,  and  P28] 
C57BL/6J mice (SLAC Laboratory Animal Company, 
Shanghai, China). The A53T transgenic mice used in 
the  present  study  [21]  were  obtained  from  Ruijin 
Hospital  affiliated  to  Shanghai  Jiaotong  University 
School  of  Medicine.  All  of  the  animal  experiments 
were performed in compliance with the institutional 
guidelines. 
Quantitative real-time reverse transcriptase 
polymerase chain reaction (qRT-PCR) 
All RNA and cDNA were prepared according to 
the protocol provided by Invitrogen (Carlsbad, USA), 
and RT-PCR was performed on a real-time PCR ma-
chine (ABI7300, USA) using a standard SYBR Green 
PCR kit (Toyobo, Japan). The reactions were run for 
40 cycles (90 °C for 15 s and 60 °C for 60 s). All of the 
samples were examined in duplicate. The following 
primers were used: mouse β4 gene (GenBankTM Ac-
cession  No.BK001031)  (5′-TTGGAGGTATCTGTGG 
GAAAGG-3′and5′-CGCTGTTATTGTAGGACCACTT
G-3′)  and  GAPDH  (5′-AGAAACCTGCCA 
AGTATGATGACA-3′and5′-GGAAGAGTGGGAGTT
GCTGTTG-3′). The relative expression of the β4 gene 
compared  with  GAPDH  was  calculated  using  the 
2-ΔΔCt method [22]. 
Preparation of membrane fractions 
Four brain and liver tissues were dissected from 
WT and A53T neonatal transgenic mice. The tissues 
were either immediately processed or snap frozen in 
liquid  nitrogen  and  kept  at  -80°C  for  future  pro-
cessing.  The  membrane  fractions  were  obtained  as 
previously described [23]. The protein concentrations 
of  high-detergent  samples  were  determined  using 
bicinchoninic  acid  assays  (Beyotime  Biotechnology, 
China). 
Antibodies 
The  rabbit  polyclonal  antibody  specific  for  the 
mouse VGSC β4 subunit was generated as previously 
described [7, 10, 24] with minor modifications. Amino 
acids 80–228 of the mouse β4 gene were selected and 
then cloned into the constructed P3 expression vector 
for  expression  of  the  mβ4  protein  in  a  prokaryotic 
system. The specificity of the β4 antibodies was con-
firmed  by  immunoblot  assay.  The  other  antibody 
used in the present study was actin (Abmart, Shang-
hai,  China).  The  peroxidase-conjugated  AffiniPure 
goat anti-mouse IgG and goat anti-rabbit IgG (Jackson 
ImmunoResearch, USA) were used as secondary an-
tibodies in immunoblot assay. The CyTM 3-conjugated 
AffiniPure  goat  anti-rabbit  IgG  (H+L)  (Jackson  Im-
munoResearch  Laboratories,  USA)  was  utilized  as 
secondary  antibody  in  immunufluorescence  experi-
ments. 
Immunoblot assay 
The  samples  (20–30  μg)  were  denatured  in  5× 
sample buffer for 5 min at 100 °C. The proteins were 
fractionated using SDS-PAGE, using either a 5% or a 
12%  gradient.  The  proteins  were  excised  from  the 
Tris-HCl gels and electrotransferred onto Nitrocellu-Int. J. Biol. Sci. 2012, 8 
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lose (NC) membrane (Millipore Corporation, Billerica, 
MA)  for  1  h  at  300  mA  and  4  °C.  The  blots  were 
blocked with 5% dried milk in TBST (10 mM Tris, pH 
7.5, 50 mM NaCl and 0.1% Tween-20, Sigma) for 2 h at 
room temperature before their incubation overnight 
at 4°C with the primary antibody (1:10,000) diluted in 
5% dried milk in TBST. The blots were washed exten-
sively  in  TBST.  The  immunoreactive  proteins  were 
detected by incubation with a 1:20,000 dilution of the 
horseradish  peroxidase  (HRP)-conjugated  goat  an-
ti-rabbit  IgG  secondary  antibodies  (Jackson  Immu-
noResearch, USA) in 5% dried milk in TBST for 2 h at 
room temperature. The signal was detected by chem-
iluminescence  of  the  HRP  substrate,  according  to 
recommendations  of  the  manufacturer  (Millipore 
Corporation, Billerica, MA). 
Deglycosylation of membrane fractions 
The  membrane  fraction  of  the  brain  and  liver 
tissues from four mice at different postnatal ages were 
prepared  as  previously  described  [23]  with  minor 
modifications. The membrane pellet was suspended 
in 100 μl of 0.2 M KCl and 10 mM HEPES at pH 7.4. 
Sodium dodecyl sulfate (SDS) was added to a final 
concentration  of  0.3%,  and  then,  10 μl  of  a 
10× glycoprotein denaturation buffer (5% SDS, 0.4 M 
DTT) was added. The reaction solution was boiled at 
100 °C for 10 min, and then, 1/10 volume of 10× G7 
buffer (0.5 M sodium phosphate) and 10% NP-40 were 
added. This was followed by the addition of 1 μl (500 
U) N-glucosidase PNGase F (New England Biolabs, 
Beverly,  MA).  The  mixture  was  then  incubated  at 
37°C for 1 h. The enzyme cleaves the glycosidic band 
between  the  N-acetylglucosamine  (GluNAc)  group 
and  the  asparagine  residues  of  N-linked  glycopro-
teins.  A  control  sample  was  prepared  without  the 
addition of PNGase F. Up to 33 μl of 5× sample buffer 
was  added  to  the  reaction.  The  proteins  were  frac-
tionated on a gradient gel as described above. 
Plasmid construction 
The full-length mouse β4 gene was synthesized 
and cloned into pUC57 (Invitrogen, USA). The mouse 
β4 mutant (β4-MUT) was created similarly to that pre-
viously described for β1 and β2 subunit mutagenesis 
[25,  26].  Each  asparagine  that  initiated  a  potential 
N-glycosylation site (Asn45, Asn71, Asn113, and Asn145) 
was changed to a glutamine residue to create the de-
glycosylated  mutant  β4-MUT.  The  mouse  sodium 
channel β1, β2, and β3 cDNAs were amplified from 
mouse brain cDNAs by PCR using the primers listed 
in  Supplementary  Material:  Table  S2  as  previously 
described  [10]  with  minor  modifications.  The  PCR 
products  were  then  subcloned  into  the  bicistronic 
vector pEGFP-N1 (Invitrogen, USA). All of the con-
structs were verified by sequencing.  
Cell culture, transient transfection and 
treatments 
The HEK-293 and Neuro2A cell lines were pur-
chased from the cell bank of the Shanghai Institute of 
Cell Biology (Shanghai, China). Cells were maintained 
in  Dulbecco’s  modified  Eagle’s  medium  supple-
mented with 10% fetal bovine serum (GIBCO Labor-
atories, Grand Island, USA). The day before transfec-
tion, cells were seeded and left to adhere overnight. 
The cells were then transfected with the β4-WT and 
the  β4-MUT  plasmids  using  Lipofectamine  2000 
(Invitrogen,  USA)  in  accordance  with  the  manufac-
turer’s protocol. 48 hours after transfection, cells were 
collected for expression analysis. For neurite growth 
analysis, cells were differentiated by treatment with 5 
mM  dbcAMP  (N6,  2’-O-dibutyryladenosine-3’,5’- 
cyclic monophosphate sodium salt) (Sigma Chemical 
Co, St. Louis, USA). 
Immunofluorescence technique 
The cells that were grown on glass cover slips 
(Corning,  USA)  were  transfected  and  differentiated 
for 1 day. Cells were fixed with 4% paraformaldehyde 
in  phosphate-buffered  saline  (PBS)  for  15  min,  per-
meabilized with 0.2% Triton X-100 in PBS for 10 min, 
washed extensively with PBS and then blocked with 
10% bovine serum albumin (BSA) (Beyotime, Shang-
hai, China) in PBS for 1 h. The primary antibody in-
cubation was performed overnight at 4°C. After sev-
eral  washings  with  PBS,  cells  were  incubated  with 
appropriate secondary antibody for 1 h and washed 
several times. The CyTM 3-conjugated AffiniPure Goat 
Anti-Rabbit  IgG  (H+L)  (Jackson  ImmunoResearch 
laboratories, UAS) was used to visualize expression. 
The samples were observed using a confocal micro-
scope (Olympus FV1000). In some experiments, nuclei 
were counterstained with DAPI (Roche, Germany). 
Quantitative measurement of neurite out-
growth 
Neurite  outgrowth  activity  induced  by  the 
β4-WT and the β4-MUT in Neuro2A cells was quanti-
fied using a confocal microscope (Olympus FV1000; 
UPLSAPO 60XW NA 1.20). This application utilizes 
three  fluorescent  channels,  for  nuclei  (DAPI),  green 
fluorescent protein (GFP+) and anti-β4 antibody (vis-
ualized  by  CyTM  3-conjugated  AffiniPure  Goat  An-
ti-Rabbit IgG (H+L)), to identify and count the Neu-
ro2a cells. An observer blind to the experimental set-
tings  then  analyzes  the  images  by  quantitating  the 
total length of the neurites of 86-150 cells from three to Int. J. Biol. Sci. 2012, 8 
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five  independent  experiments  using  the  Image-Pro 
Plus 6.0. The number of filopodia-like protrusions (of 
30 μm) on any neurite was counted from at least 20 
randomly selected cells. 
Statistical analyses  
All of the data are presented as the means ± SEM 
of at least three independent experiments. The statis-
tically significant values (*P＜0.05 or **P＜0.01) were 
determined by Student’s t-test or ANOVA followed 
by the Student-Newman-Keuls test using SPSS13.0. 
Results 
Expression of β4 subunit is higher in PD pa-
tient brain and neonatal A53T transgenic mice 
The  glycoproteins  from  PD  brain  tissues  were 
isolated  using  the  methods  described  for  CSF  [20]. 
Using a robust shotgun proteomic approach in con-
junction with an isotope-labeling technique, isobaric 
tagging  for  relative  and  absolute  quantification 
(iTRAQ),  we  generated  a  list  of  proteins  from 
top-ranked GO categories that were identified in four 
independent experiments, which are listed in Table 1. 
Several  of  these  proteins,  including  al-
pha-1-antichymotrypsin [27, 28] and sodium channel 
β4 subunit [6, 10], are known to have the potential in 
PD or other neurodegenerative disease pathogenesis. 
In addition to these proteins, many other proteins are 
known to be important in other disease pathogenesis 
but have yet to be linked to PD pathogenesis. Thus, 
we generated a list of proteins that may yield insight 
to  novel  mechanisms  underlying  PD  progression. 
Among the top-ranked proteins, β4 was selected as 
our first candidate for confirmation.  
The expression of β4 was significantly increased 
in  PD  patient  brain  tissues  and  validated  through 
RT-PCR and western blot analyses. In neonatal A53T 
mice, β4 mRNA expression increased (Fig. 1A), and in 
the  western  blot,  β4  was  expressed  at  molecular 
masses of ~38 kDa and 35 kDa (Fig. 1B). The 38 kDa 
band  appeared  as  a  strong,  slightly  smeared  band 
when compared with the 35 kDa band. The multiple 
protein  bands  were  expected  due  to  the  N-linked 
glycosylation at multiple  sites; the expression  of  β4 
was  significantly  higher  than  in  neonatal  WT  mice. 
The expression of β4 was also compared between the 
postnatal day 7 WT mice and the adults; the results 
revealed two different molecules of different masses 
in immunoblot assays. There was no change in total 
protein  between  the  two  groups  (Supplementary 
Material: Fig S2). These results indicate that β4 protein 
may exist in two different glycosylated states under 
normal  physiological  circumstances;  however,  the 
heavily glycosylated state, the 38 kDa band, appears 
prematurely early during pathogenesis. 
 
Table 1. Top-ranked proteins (Gene Ontology Analysis) with changes between Parkinson’s disease and control brains 
tissues (Glycoprotein Capture). 
IPI Number  Protein Name  Peptides Found  PD-B/Ctrl*  PD-L/Ctrl*  PD-I/Ctrl* 
IPI00793751.1  MFAP4 uncharacterized protein MFAP4  7  0.46 ± 0.13  0.49 ± 0.06  1.03 ± 0.06 
IPI00328113.2  FBN1 Fibrillin-1 precursor  6  0.78 ± 0.03  1.17 ± 0.11  1.72 ± 0.13 
IPI00329573.9  COL12A1 Isoform1of Collagen alpha-1(XII) chain precursor 6  0.93 ± 0.14  1.82 ± 0.07  1.55 ± 0.12 
IPI00292732.3  FMOD Fibromodulin precursor  4  1.20 ± 0.08  2.11 ± 0.21  1.44 ± 0.16 
IPI00009111.1  TPBG Trophoblast glycoprotein precursor  8  1.48 ± 0.37  1.83 ± 0.22  1.29 ± 0.13 
IPI00847635.1  SERPINA3 Isoform1of Alpha-1-antichymotrypsin precur-
sor 
15  1.62 ± 0.14  1.38 ± 0.06  1.45 ± 0.09 
IPI00015872.3  TSPAN8 Tetraspanin-8  4  2.13 ± 0.25  1.37 ± 0.13  1.44 ± 0.13 
IPI00514804.1  SCN4B Isoform2 of Sodium channel subunit beta-4 pre-
cursor 
4  2.48 ± 0.30  4.44 ± 0.80  2.12 ± 0.28 
Ctrl, Control; PD-B, PD-brainstem; PD-L, PD-limbic; PD-I, PD-isocortex. The protein names are from the IPI human protein database (Ver-
sion 3.18). 
*Peptides found denotes the sum of all the different peptides found and is relatively quantified from the proteins shown in four replicate 
experiments.  
The ratio shown is the means ± SEM of four independent experiments. 
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Fig 1. Expression level of the sodium channel β4 subunit in neonatal mice. (A) Real-time PCR analysis was performed, and all of 
the values obtained were normalized with respect to the level of GAPDH. The level of β4 mRNA markedly increased in neonatal A53T 
mice (**p < 0.01). The values are expressed as the means ± SEM (**p < 0.01 compared with the controls). (B) Confirmation of β4 
expression through western blot analysis. Equal amounts (30 μg) of neonatal WT and A53T mice brain tissue samples (four per group, two 
groups in total) were sequentially analyzed with anti-β  4  antibodies, and actin was used as the loading control. β4 expression increased 
under disease progression. WT: neonatal wild-type mice; A53T: neonatal PD transgenic mice. 
 
Immunoblot analysis of β4 reveals develop-
mental regulation of the glycosylation of this 
subunit 
Immunoblot analysis of the membrane fractions 
showed  that  WT  mice  only  contained  the  ~35  kDa 
band until postnatal day 7 (Fig 2A). The Na+ channels 
are  heavily  glycosylated  [12,  29];  therefore,  the  de-
velopmentally regulated N-linked glycosylation of β4 
is likely the source of the 38 kDa molecular weight 
band  in  adult  tissues.  The  ~35  kDa  band  was  at-
tributed to an expression state that is either glycosyl-
ated  or  a  nonspecific  band.  To  test  this  hypothesis, 
membrane fractions were treated with the glycosidase 
enzyme PNGase F and analyzed by immunoblot as-
say. The PNGase F cleaved the glycosidic bond of the 
N-acetylglucosamine linked to the aspargine (N) side 
chain of the N-glycosylated proteins. Fig. 2B showed 
the effect of the enzymatic treatment on the size of the 
β4 protein of the membrane fractions from P0, P6, P7, 
P28,  and  adult  WT  mice.  The  enzymatic  treatment 
converted  the  38  kDa  protein  to  a  faster  migrating 
band in P7, P28 and adult WT mice compared with 
the untreated samples. There was no change observed 
between  the  enzymatically  treated  and  untreated 
samples in P0-P6 tissues, and there was no expression 
in  liver  and  lung  tissues  (data  not  shown).  These 
findings  clearly  showed  that  β4  was  heavily  glyco-
sylated  in  brain  tissues  and  was  developmentally 
regulated.  Fig.  2C  showed  the  mobility  shift  of  the 
immunoreactive  protein  after  PNGase  F  treatment 
and also indicated that the ~38 kDa protein appeared 
prematurely in the neonatal A53T mice brain fractions 
and was heavily glycosylated. 
Immunoblot analysis of the heterologous ex-
pression system reveals that β4 subunit was 
glycosylated in the mature protein 
To  examine  β4  subunit  in  mouse  brains,  we 
generated a polyclonal antibody. To check the speci-
ficity of the antibody, we expressed the mouse sodi-
um channels β1-β4 individually in HEK-293 cell line 
and  tested  for  their  immunoreactivities  by  western 
blot. As shown in Fig. 3A, the β4 antibody gave no 
signal against the recombinant β1, β2, and β3 subu-
nits. In contrast, this antibody strongly recognized the 
β4 subunit and appeared as strong, slightly smeared 
bands, as described in the brain tissue above. To ex-
amine whether the 35 kDa protein exists in another 
glycosylated  state,  we  transiently  expressed  the 
β4-WT and the β4-MUT plasmids (especially when the 
expression of GFP was removed) in cultured cells. The 
anti-β4 antibodies were highly specific to the β4-WT 
and the β4-MUT proteins in membrane fractions iso-
lated from cells in immunoblot analysis. Two immu-
noreactive  proteins  of  different  molecular  weight 
were observed, and the molecular weight difference 
was  consistent  with  the  results  observed  in  the  en-
zymatically treated and untreated samples above (Fig. 
3B). These results indicated that in the brain tissues, 
the β4 protein that was heavily glycosylated was ex-
pressed as the 38 kDa band, and the 35 kDa band was 
demonstrated to be a nonspecific protein. Int. J. Biol. Sci. 2012, 8 
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Fig 2. Immunoblot assays show the developmental regulation and glycosylation of β4 subunit. (A) The ~38 kDa band was 
not expressed until postnatal day 7 in wild-type mice. (B) The treatment of the membrane fractions from the P7, P28 and adult brain 
tissues with glycosidase PNase F (Enz) converted the immunoreactive proteins into a faster migrating species. P0 and P6 show the 
immunoreactive proteins without changes between the treated and untreated samples. (C) The similar treatment of the membrane 
fractions from neonatal A53T mice brain tissues converted the ~38 kDa protein into a faster migrating species, but there is no change in 
the 35 kDa band with or without PNGase F treatment. The + and – signs indicate the treated and untreated samples, respectively. WT: 
wild-type mice; A53T: PD transgenic mice; Ad: adult wild-type mice. 
 
 
Fig 3. Immunoblot analysis reveals the expression of β4 subunit. Different cell lines were individually transfected with vector, 
β1~β4, and β4-MUT expression plasmids. (A) To analyze the specificity of the anti-β4 antibody, HEK-293 cells were transfected indi-
vidually with the β1~β4 expression plasmids. Purified membrane proteins (20 μg) were fractionated by SDS-PAGE, immunoblotted, and 
probed using an anti-β4 antibody. (B) The western blot analysis of β4-WT and β4-MUT protein expression minus the expression of GFP 
after transfection in cultured cell lines. The molecular weight difference was consistent with the results observed in the enzymatically 
treated and untreated brain samples. β4 protein is heavily glycosylated, and the ~35 kDa band expressed in the brain membrane fractions 
is demonstrated to be a nonspecific band. β4-WT: β4-wild-type plasmid; β4-MUT: β4 deglycosylated mutant plasmid. 
 
 
Overexpression of β4-WT and β4-MUT ex-
tends neurite length and increases the number 
of filopodia-like protrusions 
Voltage-gated sodium channel β subunits serve 
as cell adhesion molecules, based on structural and 
amino acid homologies [30, 31]. In addition, β4 con-
tains four potential N-linked glycosylation sites in the 
extracellular  region,  and  the  expression  of  β4  in-
creased  under  disease  progression.  Thus,  we  ex-
pressed the β4-WT and β4-MUT plasmids in Neuro2a 
cells to gain additional insight into the function of the 
N-glycosylation  of  β4  subunit.  Overexpression  of Int. J. Biol. Sci. 2012, 8 
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β4-WT induced neurite extension and increased the 
number of filopodia-like protrusions [6, 10]. To inves-
tigate the morphological changes between the β4-WT 
and  β4-MUT  expressing  cells,  Neuro2a  cells  were 
transiently transfected with the β4-WT, β4-MUT and 
vector  plasmids.  Quantification  of  the  neurites  was 
significantly  longer  in  cells  expressing  β4-MUT 
(69.34±4.2μm) when compared with cells expressing 
β4-WT (50.97±2.7μm) and vector (31.43±1.5μm) (Fig. 4 
A, B). In addition to the extension of neurites, over-
expression of β4-MUT also increased the number of 
filopodia-like protrusions (3.7±0.3 per 10 μm of neu-
rite)  when  compared  with  cells  expressing  β4-WT 
(1.8±0.1  per 10  μm)  and  vector  (0.7±0.1  per  10  μm) 
(Fig. 4 C, D). The same features of β4-MUT and β4-WT 
induced protrusions, which are similar to the small, 
thin, and headless dendritic filopodia, were observed 
as previously reported [6, 32]. These results indicated 
that the β4-MUT modulated neurite outgrowth activi-
ties  and  spine  formation  in  cultured  cells;  in  other 
words, the N-linked glycosylation of the β4 protein 
may be involved in neurite degeneration.  
 
 
 
 
Fig 4. Overexpression of β4-WT and β4-MUT induces neurite extension and increases the formation of filopodia-like 
protrusions in Neuro2a cells. (A, B) Overexpression of β4-WT and β4-MUT in Neuro2a cells displayed a marked alteration in cell 
morphology. High-magnification images of Neuro2a cells overexpressing vector, β4-WT and β4-MUT immunostained by anti-β4 (red) and 
GFP+ (green) are shown. Scale bar 30 μm for A; Scale bar 5 μm for B. (C) The quantification of the average neurite extension induced by 
β4-WT and β4-MUT. The average neurite length for cells overexpressing β4-WT and β4-MUT were significantly greater than those for 
the vector control transfected cells (**p < 0.01); the average neurite length for the β4-MUT overexpressing cells were higher than the 
β4-WT transfected cells (*p < 0.05). (D) The quantification of the number of filopodia-like protrusions. The cells overexpressing β4-WT 
and β4-MUT had a significantly increased number of filopodia-like protrusions (*p < 0.05, **p < 0.01). The number of filopodia-like 
protrusions in the β4-MUT transfected cells was significantly higher than the β4-WT cells (*p < 0.05). The values in the histograms are 
means ± SEM. Int. J. Biol. Sci. 2012, 8 
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Discussion 
Glycosylation represents the most common and 
complicated  post-translational  modifications  (PTMs) 
and may contribute to the progression of disease [14, 
15]. In the present study, quantitative data of aberrant 
glycoproteins in PD patient brain tissues are listed in 
Table 1 from four independent experiments. The ex-
pression of β4 was significantly higher in disease tis-
sues than in controls. One PD transgenic mouse line, 
A53T, was used in this study. Initially, we identified 
that  β4  was  significantly  up-regulated  in  the  brain 
tissue  of  A53T  mice.  There  were  two  molecular 
weight  bands  in  neonatal  A53T  mice,  but  only  the 
smaller  one  existed  in  neonatal  WT  mice.  We  first 
thought that there would be two β4 protein bands that 
would  indicate  different  glycosylation  patterns,  but 
the ~35 kDa band was shown to be a nonspecific band 
by its changes in mobility after PNGase F treatment 
and was expressed with β4-MUT plasmid in heterol-
ogous expression systems. As we know, there are four 
potential  glycosylation  sites  in  the  extracellular  re-
gion, and the ~38 kDa band is expressed until post-
natal day 7; these results showed that the glycosyla-
tion of β4 subunit underwent developmental regula-
tion after birth. The extra mass is estimated to be at-
tributed to carbohydrates. 
Immunocytochemical  analysis  shows  that  filo-
podia-like protrusions contain F-actin and are similar 
to dendritic filopodia, which are highly motile struc-
tures that play important roles in the process of ax-
on-dendrite contact and thought to be a precursor of 
the spine [6, 32]. The β4 subunit also served as CAMs 
can promote neurite outgrowth and  is the only en-
dogenous  open-channel  blocker  responsible  for  re-
surgent current [8, 9]. However, we noticed that the 
effect  of  β4-WT  overexpression  on  neurite  morpho-
logical changes observed in our study is  somewhat 
different from that reported in a previous study [10]. 
This could be due to the different culture conditions 
and the level of protein expression from transfection. 
Because we observed similar effects in cultured cells, 
it  is  worth  noting  that  overexpression  of  β4-MUT 
could  promote  neurite  outgrowth  in  Neuro2a  cells 
and increase the number of filopodia-like protrusions 
when compared with the cells expressing β4-WT and 
vector plasmids. These results suggested that the ex-
tracellular domain of β4, especially the N-linked oli-
gosaccharides,  may play important roles in  neuritic 
degeneration.  
Glycosylation  alters  many  properties  of  mem-
brane proteins, such as targeting, folding, affinity, and 
cell surface expression [33-35]. Furthermore, the car-
bohydrate  structures  of  proteins  on  the  cell  surface 
have been shown to correlate with disease, for exam-
ple, the N-linked oligosaccharides of the 5-HT2A re-
ceptor  are  important  for  JC  virus  infection  in  PML 
[36]. We examined that the expression of β4 markedly 
increased in the neonatal PD transgenic mice. We also 
suggested  that  the  β4  protein  underwent  develop-
mental regulation and was involved in morphological 
changes in Neuro2a cells. Taken together, these data 
suggest that the sialic acid component of β4 protein is 
required  for  proper  physiological  function,  but  its 
abnormal glycosylation process may  be involved in 
neuritic degeneration. 
The β4 subunit has an important effect on neu-
rons and other excitable cells, regardless of whether 
the cells express other β subunits or not [7]. The β4 
subunit  caused  negative  shifts  in  the  voltage  de-
pendence of activation and overrode other subunits’ 
effects; the resulting action potentials increased neu-
ronal sensitivity to excitatory inputs in cells express-
ing the β4 subunit. PD-linked parkin is involved in 
regulating mitochondrial dynamics and the stability 
of excitatory glutamatergic synapses [37, 38]. The ex-
citatory response produced by the disruption of par-
kin and an increased β4 expression may contribute to 
the pathophysiology of PD. Sodium channel subunits 
are  glycosylated  [39],  thus,  the  extent  and  type  of 
glycosylation during different stages of development, 
in different cell types or during different disease pro-
gressions may be important in their ability to modu-
late  channel  activities  [40];  glycosylation  of  the  dif-
ferent β subunits has different mechanisms by which 
sodium channel activity is modulated [25, 26], so dif-
ferent glycosylations of auxiliary subunits may inter-
fere with neuronal function at multiple levels, heavy 
glycosylation of β4 in adult tissues may be essential 
for the shifts in sodium channel gating. However, β4 
appears  prematurely  in  the  disease  state,  and  in-
creased  expression  in  neonatal  PD  transgenic  mice 
may imply that N-linked oligosaccharides play roles 
in  neuritic  degeneration.  Its  sialic  acid  component 
may  regulate  cell  adhesion,  migration  and  sodium 
channel activities. 
In conclusion, this study provided a new insight 
into  the  role  of  protein  glycosylation  under  disease 
progression. We demonstrated that the expression of 
β4 was up-regulated in human PD brain tissue and in 
neonatal  transgenic  mice.  We  also  proved  that  the 
glycosylated β4 is developmentally regulated and that 
the N-linked oligosaccharides are involved in neurite 
degeneration in cultured cells. To confirm the role of 
the sialic acid component of β4 during PD progres-
sion, further studies will focus on the mechanisms of 
neuritic degeneration and the effects of the oligosac-
charides on the sodium channel activities. Int. J. Biol. Sci. 2012, 8 
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Table S1:   Summary of control and PD cases.   
Table S2:   The nucleotide sequence for amplifying β 
subunit cDNAs.  
Fig S1:  MS, MS/MS and iTRAQ of sodium channel β4 
subunit.  
Fig S2: Developmental expression of the sodium 
channel β4 subunit in WT mice. 
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